Transcode Therapeutics Faces Delisting
Transcode Therapeutics receives notice of potential delisting due to failure to meet continued listing standards. The company's stock may be transferred to a different exchange.
Filed: 2026-05-26 AccNo: 0001104659-26-065959 Size: 205 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing